The document discusses advances in diagnostic aids for periodontal disease, highlighting limitations of conventional methods and emphasizing new techniques in clinical, radiographic, microbiological, and immunological assessments. It details various diagnostic modalities, including advanced probes, digital radiography, and molecular biology techniques, to enhance accuracy in identifying periodontal conditions. Ultimately, the focus is on disease prevention, early detection, and tailored treatments to improve patient outcomes.
Introduction to advanced diagnostic aids in periodontics, covering contents of the presentation.
Diagnosis defined as identifying disease; importance in treatment planning emphasized. Examines clinical evaluations for gingival inflammation and periodontal destruction.
Limitations in conventional periodontal diagnosis are discussed, emphasizing the multifactorial nature of periodontal disease including host response and genetic factors.
Focus on disease prevention and early intervention is highlighted. Diagnostic aids include clinical, radiographic, microbiologic methods.
Overview of advanced probes and radiographic techniques, emphasizing digital imaging, automated systems, and microbial analysis.
Methods to determine periodontal disease activity using crevicular contents and subgingival temperature measurements.
Discussion on various periodontal probes, detailing advancements from first to fifth generation probes.
PSR system for screening dental patients for periodontal diseases, highlighting the importance of detection.
Limitations of conventional radiography and advances like digital and subtraction radiography for better visualization.
CT scanning's role in implant evaluation; advantages and disadvantages including detailed imaging of jaw structures.
Advantages of CBCT for creating virtual patients and treatment planning in dental evaluations.
Insights into the role of specific bacteria in periodontal disease and diagnostic techniques used for identification.
Overview of various microbiological testing methods, including culturing, immunodiagnostic tests, and enzymatic methods.
Molecular techniques such as DNA probes and PCR for detecting periodontal pathogens.
Focus on tests that characterize inflammatory response, including mediators and tissue breakdown products.
Overview of microbiologic, biochemical, and genetic test kits, emphasizing their significance in periodontal disease management.Conclusion summarizing the necessity for accurate diagnosis in periodontal treatment along with references.
Contents
 Introduction
 Limitationsof conventional periodontal diagnosis
 Advances In Clinical Diagnosis
 Advances In Radiographic Assessment
 Advances Microbiologic Analysis
 Advances In Characterizing The Host Response
3.
Introduction
• Definition :Diagnosis is defined as identifying the disease
from an evaluation of history, signs and symptoms, laboratory
tests and procedures.
• Importance :
a. It identifies and indicates the nature of etiological factors
b. Indicates the nature of pathological processes
c. It is essential for treatment planning
4.
types of diagnosis
Provisionaldifferential comprehensive
therapeutic
emergency
Diagnostic aids in periodontics conventional
advanced
• Tissue destruction( Periodontitis)
Loss of connective tissue
clinical radiographic
attatchment loss bone loss
 Gives historical evidence of damage
 Identify and quantify current clinical signs of inflammation
7.
Limitations
• Does notprovide cause of condition
• Susceptibility of patient
• Cannot reliably identify sites with ongoing periodontal
destruction
• Cannot differentiate whether response to therapy is positive or
negative
• Consideration shouldbe given microbiologic
immunologic
systemic
genetic
behavioural factors
in addition to clinical and radiographic parameters.
10.
• The focusis now disease prevention, early discovery, and
intervention to minimize treatment, thus enabling the most
desirable outcomes.
• Diagnostic modalities available to clinicians today expand
greatly on the foundation of a comprehensive visual
assessment, which has been and will be the cornerstone of the
diagnostic process.
11.
Classification
• Aids usedin clinical diagnosis
i. Conventional probes – regular examination
ii. Millimeter probes – for gingival bleeding
iii. Pressure sensitive probes
 Other clinical diagnostic aids
i. Filter papers- for measuring GCF
ii. Periotron 6000- for measuring GCF
iii. Olfactometer- for mouth odors
iv. Mobilometer- for tooth mobility
v. PSR- for faster screening and recording of PD
12.
• Aids usedin radiographic diagnosis
i. IOPA radiographs
ii. Ortho-pantomograph
iii. Xero-radiography
• Aids used in microbial diagnosis
i. Direct examination
a. Light microscopy
b. Dark field microscopy
ii. Culture tests
a. Aerobic culture
b. Anaerobic culture
13.
• Aids usedin immunological diagnosis
i. Immunofluorescense- direct and indirect
ii. Polymerase chain reaction
iii. Latex agglutination
iv. Flow cytometry
v. ELISA
• Biochemical diagnosis
i. Studies for prostaglandins
ii. Studies for collagenase
• Other diagnostic aids
i. study casts
ii. FSEIA
iii. N-benzoyl-DL- arginine 2- naphthylamide (BANA)
14.
Advanced diagnostic aids
•Advanced periodontal probes
i. Automated controlled force probes
ii. Thermal periodontal probes
• Advanced diagnostic aids in periodontal radiography
i. Digital radiography
ii. Substraction radiography
iii. Digital substraction radiography
iv. Transmission radiography
v. Magnetic resonance imaging
vi. Computerized tomography
vii. Nuclear medicine bone scan
15.
• Advanced diagnosticaids in microbiologic analysis
i. Advances in culturing technique
ii. Advances in immunodiagnostic methods
iii. Advances in enzymatic methods
iv. Advances in nuclear biology- PCR and DNA probes
• Advanced diagnostic aids in charting the host response
i. Assessment of inflammatory mediators and products
ii. Assessment of tissue breakdown products
iii. Assessment of host derived enzymes
16.
• Advanced diagnosticaids to determine periodontal disease
activity
i. Crevicular contents
• Products of bacteria
• Products of host cells and host immunity
ii. Markers in peripheral blood
• Neutrophil functional profile
• Monocyte responsiveness to LPS
• Circulating antibodies to plaque bacteria
iii. Detection of specific periodontal pocket bacteria
a. DNA probes
b. BANA hydrolysis
c. Antibody techniques
17.
Advances in clinicaldiagnosis
• Degree of gingival inflammation
a. redness and swelling
b. gingival bleeding
• Gingival bleeding ∞ plaque accumulation
gingival inflammation
(Greenstein G et al 1981)
size of inflammatory infiltrate
probability of losing attatchments
(Lang et al.1991)
18.
Gingival temperature
• Thermalprobes are sensitive diagnostic devices for measuring
early inflammatory changes in gingival tissue.
(Kung et al 1990)
• Commercially available system periotemp probe
• Individual temperature differences are compared with those
expected for each tooth and higher temperature pockets are
signaled with a red emitting diode.
• Subgingival temperature at diseased sites is increased as
compared to normal healthy sites
19.
• Elevated subgingivaltemperature ∞ attatchment loss
& elevated propertions of
periodontopathic bacteria
( Haffajee et al.)
20.
Periodontal probes
• Mostwidely used
• Clinical assessment of connective tissue destruction in
periodontitis
• Gold standard – recording changes in periodontal status
• Probing depth is measured from the free gingival margin
(FGM) to the depth of the probable crevice.
• not the most objective measure of loss of periodontal tissues
21.
• CAL isa more objective measure of loss of Existing
periodontal support.
• CAL also does not give any indication of current disease
activity.
• When interpreting the PD and CAL measurements made with
conventional periodontal probes, it is important to consider
that these values depend on the inflammatory state of the
tissues.
22.
Classification of periodontalprobes depending
on generation.
1.First generation probes:(conventional probes)
Conventional manual probes that do not
control probing force or pressure and
that are not suited for automatic data
collection.
eg: Williams periodontal probe
CPITN probe
UNC-15 probe
University of Michigan’O’ probe
Goldman Fox probe
Glickman probe
Merritt A and B probe
23.
2.Second generation probe:
(Constantforce probe)
Introduction of constant force or pressure sensitive probes
allowed for improved standardization of probing.
e.g.: Pressure sensitive probe
Constant pressure probe
3.Third generation probe:(Automated probes)
Computer assisted direct data capture was an important step in
reducing examiner bias and
also allowed for generation probe precision.
e.g.: Toronto probe
Florida probe
Interprobe, Foster Miller probe.
24.
4.Fourth generation probes:(Threedimensional probes)
Currently under development, these are aimed at recording
sequential probe positions along a gingival sulcus.
An attempt to extend linear probing in a serial manner to take
account of the continuous and three dimensional pocket that
is being examined.
5.Fifth generation probe:(Noninvasive)
Three dimensional probe.
Basically these will add an ultrasound to a fourth generation
probes.
If the fourth generation can be made, it will aim in
addition to identify the attachment level without
penetrating it.
e.g.: Ultra sonographic probe.
25.
Florida probe:
Tip is0.4mm
Sleeve- edge provides reference
to make measurements
Coil Spring; provides constant probing force
Computer for data storage.
27.
• Disadvantages ofFlorida probe.
Lack of tactile sensitivity
Fixed probing force
Underestimation of deep periodontal pockets.
Other electronic probes:
Improvised Florida PASHA probe
Interprobe
Perioprobe
Foster Miller probe
Toronto Automated ( difficult to reproduce patient head
position and in 2nd and 3rd Molar area.)
28.
PSR system
• Toscreen dental patients to facilitate the detection of mild
forms of periodontal diseases and to identify individuals who
have previously undetected periodontitis.
• It is designed for general dental practitioner to identify the
patient’s requiring periodontal care and to determine the type
of care required.
29.
• Based onthe worst site per sextant.
• If one or more sextants show significant signs of disease,
clinician is advised to do a complete periodontal examination
and charting
30.
Advances in RadiographicAssessment
• Dental Radiography are traditional method to assess
destruction of alveolar bone.
• Problems with conventional Radiography:
 Variation in projection geometry
 Variation in contrast and density
 Masking by other anatomic structures.
 They are very specific but lack sensitivity.
31.
Digital Radiography
• Computerizedimages.
• Image property almost equal to conventional radiographs
• 1/3rd to half reductions in radiation dose.
32.
Substraction Radiography
• Wellestablished in medicine
• Introduced in Periodontal diagnosis
• Principle: Serial radiographs converted to digital images
superimposed composite image– Quantitative changes
• Changes in density and volume of bone
a. can be detected as lighter areas (bone gain)
b. Dark areas (bone loss)
33.
• Perfect accuracyat a lesion depth of 0.49 mm
( Grondhal et al 1988)
• Limitations: needs paralleling technique and accurate
superimposition.
34.
Diagnostic Subtraction Radiography
•Positioning device during film exposure
specialized software designed for digital image subtraction
using conventional personal computers
• Applies an algorithm that corrects for the effects of angular
alignment discrepencies and provides some degree of
flexibility in imaging procedure
35.
Computer Assisted DensitometricImage Analysis
(CADIA)
Video cameras
measures
light transmitted through Radiographs
signals from camera
converted into
gray scale images
camera interfaced with image processor
+ computer
36.
• Offers objectivemethod for following alveolar bone density
changes quantitatively over time.
• Higher sensitivity
• High degree of reproducibility
• accuracy
• A thinfan beam of X-Rays rotates around the patient to
generate in one resolution a thin axial slice of the area of
interest.
• Multiple overlapping axial slices are obtained by several
revolution of the X-ray beam until the whole area of interest is
covered.
• With the help of a computer and sophisticated Algorithms
these slices are then used to generate a three dimensional
digital map of the jaw which help in evaluation of the implant
patient.
39.
• Specialized softwarecan be used to generate appropriate views
that best depict the dimensions of the jaws and the location of
important anatomic structures.
• DENTAL VIEWS OBTAINED FROM A CT SCAN
INCLUDE:-
» 1. AXIAL
» 2. PANORAMIC
» 3. CROSS-SECTIONAL. Views of the Jaws.
41.
 ADVANTAGES ofComputed Tomography
 1. True cross sections offer a precise and detailed
evaluation of the height and width of the ALVEOLAR
RIDGE.
 2. The images can be adjusted and printed without
magnification, facilitating measurements directly on the
prints or films with standard rulers.
 3. Various anatomic structures can be visualized and
analyzed at all the Coordinate axis.
 1. Superioinferior
 2. Anteroposterior
 3. Buccolingual
42.
– Images ofthe entire arch several edentulous areas can be
visualized with single examination.
– The Bone and soft tissue contrast and resolution are
excellent for the diagnostic task.
43.
 DISADVANTAGES ofComputed Tomography
 specialized equipment and setting.
 Radiologists and Technicians need to be knowledgeable
of the anatomy, anatomic variants and pathology of the
jaws as well as considerations pertinent implant treatment
planning.
 higher radiation dose to the patient as compared to other
modalities used during implant treatment planning.
 it delivers radiation to whole arch.
 Metallic Restorations can cause ring artifacts that impair
the diagnostic quality of the image, it is challenging to the
patients having heavy metallic restored dentition.
44.
CONE-BEAM COMPUTED TOMOGRAPHY
•Cone-Beam Computed Tomography (CBCT) is a new
imaging modality that offers significant advantages for the
evaluation of implant patients.
45.
• The 3-D CBCT images canbe combined with high precision
3D visible light (photographic) surface images to create a
virtual patient that accurately displays both hard and soft tissue
structures.
• This multi- modal image image visualization enables a
treatment platform that allows assessment of the patient’s
present condition, planning and stimulation of treatment
options, progress monitoring and evaluation of outcomes.
46.
Advances in MicrobiologicAnalysis
• Strong evidence for actinomycetemcomitans (Aa),
Porphyromonas gingivalis (Pg), and Tannerella forsythia
(Tf).
• Other organisms that are thought to have etiologic role are
Camphylobacter rectus, Eubaterium nodatum,
Fusobacterium nucleatum, Peptostreptococcus micros,
Prevetolla intermedia and Prevetolla nigrescens,
Trepenoma Denticola
47.
• Microbiologic tests(that can identify)
a. Can support diagnosis of various Periodontal disease.
b. Can tell about initiation & progression
c. Active & Inactive
d. Can also be used to monitor Periodontal therapy
whether it is suppressed/ eradicated.
• Several studies
(-)nce of Pathogens better periodontal health
(+)nce of pathogens periodontal disease
48.
• Bacterial culturing
•Direct microscopy
• Immunodiagnostic methods
• Enzymatic methods
• Diagnostic assays based on molecular biologic techniques
49.
Bacterial culturing
• Historically,widely used in characterizing composition of
subgingival microflora.
• Plaque sample anaerobic culture
selective non-selective
Advantage: 1. clinician can obtain absolute or relative count
2. invitro method for antibiotic susceptibility
50.
• Limitations :
i.Culture can grow only live bacteria.
ii. Sensitivity is low
iii. Requires sophisticated equipment and experienced personnel.
iv. Time consuming
v. expensive
51.
Direct microscopy
• Darkfield
Direct microscopy alternative to culture methods
• Ability to assess morphology
& motility in plaque.
• Dark field microscopy seems an unlikely candidate as a
diagnostic test of destructive periodontal diseases.
52.
Immunodiagnostic methods
• Itemploys Antibody
that recognize
specific bacterial antigen
• Various procedures:
a. Direct & indirect immunofluorescence assays
b. Flow cytometry
c. ELISA
d. Membrane assay
e. Latex agglutination
53.
Immunofluorescence assay
• DirectIFA: AB conjugated with Fluorescein marker +
Bacteria ( Antigen) = Immuno complex
• Indirect IFA: Primary AB + Bacteria= Immune Complex+
Secondary Fl conjugated AB
Cytofluorography/ Flow cytometry
Bacterialcells+ species specific AB
+ Secondary FL Conjugated AB
Introduced in flowcytometer
Bacterial cells is separated into
single cell suspension-
 passes through the tube
Cells identified by lasers
56.
• merits :
rapididentification
labels bacterial cells species specific antibody
fluorescin conjugated secondary
antibody
• Demerits:
sophistication
expensive
57.
ELISA= Enzyme LinkedImmunosorbent Assay
Similar AB and Antigen reaction, but the fluorescence is read
using a photometer.
Evalusite: commercially available kit to detect Aa,Pg and Pi.
59.
 Well withprecoated antibody + Sample
to be tested= immune complex
Specific antigen bind to the antibody +
Secondary antibody added.
Immunofloresence dye bound to
secondary antibody
 Substrate added which changes the
color of the solution
Amount of florescence checked by
photometer (450nm)
60.
• Latex AgglutinationTest
Latex beads coated with species specific AB when beads come
in contact with specific species in sample they bind and
agglutination occurs clumping of beads is visible test
positive.
Advantages:
Simple and Rapid testing
Higher sensitivity and specificity.
61.
Enzymatic methods
• Bacteriarelease specific enzymes. Certain group of species
share common enzymatic profile.
e.g. Tf, PG, Td, and Capnocytophaga species release trypsin
like enzyme.
• Enyme hydrolyses specific substrate (BANA) release
cromophore ( B-naphtalamide) Cromophore changes color
on addition of a substance( fast garnet)
62.
Perioscan is apopular diagnostic kit uses BANA reaction.
Disadvantage:
May be positive in clinically healthy site
Cannot detect disease activity
Limited organisms detected
Other pathogens may be present if it’s negative.
63.
Molecular Biology Techniques
•Basic Principle: Analysis of DNA, RNA and protein structure.
Hybridization: Pairing of complimentary strands of DNA to
produce a double stranded DNA
.
Nucleic acid probe: is a known DNA/RNA which is synthesized
artificially and labeled with a enzyme or a radioisotope for
detection when placed in a plaque sample
64.
DNA Probe: usesa segment of a
single stranded DNA, labeled
with a enzyme of a radio
isotope, that is able to hybridize
to a complimentary nuclei
strand, and thus detect presence
of target microorganism.
65.
DNA Probe
Whole genomic:Targets the whole DNA strand rather then a
specific sequence or gene.
High chances to cross react with non target microorganism
Lower sensitivity and specificity.
• Checkerboard DNA-DNAHybridization Technology:
Developed by Socransky et.al.
40 bacterial species can be detected using whole genomic
digoxigenin-labeled DNA probes.
Large number of samples can be tested and upto 40 oral species
detected with a single test.
68.
Advantages of DNAprobes as compared to bacterial
culturing.
1. More sensitive and specific
2. Requires as less as 104 cells of each species to be
detected.
3. Multiple species detected with a single test
4. Does not require viable bacteria
5. Large number of samples can be assessed.
Disadvantage:
1. Expensive
2. Expert personnel to carry out the test
3. Not easily available
69.
• Polymerase ChainReaction (PCR):
Involves amplification of a region of DNA by a primer specific to
the target species.
If there is amplification then it indicates the presence of the target
species in the sample.
70.
Advantages:
1. High detectionlimit. As less as 5- 10 cells can be
amplified and detected.
2. Less cross reactivity under optimal conditions
3. Many species can be detected simultaneously
Disadvantage:
1. Small quantity needed for reaction may not contain the
necessary target DNA
2. Plaque may contain enzymes which may inhibit these
reactions.
71.
Advances in characterizingthe host response
• Diagnostic tests have been developed that add measures of the
inflammatory process to conventional clinical measures.
• These diagnostic tests gives information about
pattern of destruction
current activity of disease
rate of disease progression
extent & severity of further breakdown
response to therapy
72.
• So, knowingabout disease destructive process-
clinician can individualise their therapeutic approach,
and customize the treatment.
• Source of samples may be; GCF, Saliva, or Blood.
• GCF is most commonly used, where as saliva is recently been
researched.
• Assessment of Host response
i. Inflammatory mediators and products
ii. Host derived enzymes
iii. Tissue breakdown products
73.
Inflammatory mediators &products:
• Cytokines- potent local mediators of inflammation
produced by variety of cells
• GCF- TNF α
IL-1
IL-6
IL-8
• Good correlation with disease status and severity but not
disease progression
74.
• In untreatedperiodontitis- concentration of PGE2 increased
during active phase of periodontal destruction.
• Cytokines ∞ disease severity & status
• PGE2 ∞ active phase of periodontal disease
75.
Host derived enzymes:
•Matrix components are dissolved by either
a. ECM metalloproteinase dependent
b. Plasmin dependent cleavage reactions
• Proteases and enzymes involved in these processes may be
used as diagnostic aids.
For periodontal diagnosis,the ideal diagnostic test should be
• Quantitative.
• Highly sensitive method capable of analyzing a single
periodontal site in health as well as disease.
• Reproducible.
• Highly specific.
• Simple to perform.
• A rapid, one or two stage procedure.
• Non-invasive.
• Versatile in terms of sample handling, storage and transport.
• Amendable to chairside use.
• Economical. ( Chapple 1997)
79.
Chairside periodontal testkits can be categorized as
• Microbiologic tests
• Biochemical test kits
• Genetic kits
Microbiological test kits
The bacteriological tests
(Microscopy, Culture, Omnigene, Affirm DP and Evalusite) are
mainly aimed at spirochetes, Aa, Pg and Pi.
Microbial tests can also be used to monitor periodontal therapy
directed towards the suppression or eradication of
periodontopathogenic microorganisms
80.
Omnigene
• DNA probesystems
• available for the detection of A. actinomycetemcomitans, P.
gingivalis, P. intermedia, F. nucleatum, C. rectus, T. denticola
and E. corrodens.
81.
Evalusite
• Evalusite isa kit that employs a novel membrane-based
enzyme immunoassay for the detection of three putative
periodontopathogens: Aa, Pg and Pi.
• a pink spot is displayed if the test organism is present.
• The main weaknesses of this test kit reside in
• 1) the assumption that the three detected organisms are
causing disease;
• (2) it is a multistage test;
• (3) it has a subjective calorimetric end point and (4) there is no
permanent record of the results.
82.
PerioScan®
• Perioscan isa diagnostic test kit that utilizes the BANA (N-
benzoyl-DL-arginine-2-naphthylamide)-hydrolysis reaction,
• developed to detect bacterial trypsin-like proteases in the
dental plaque
83.
Biochemical test kits
•Perio 2000- to evaluate VSCs
• Prognos- Stik- to detect elevated levels of MMPs
• Perio- Check- to measure neutral protease activity
• PerioGard- to detect AST
• Pocket Watch- simple method for AST
84.
Genetic test kits
•Various gene polymorphisms are considered to be risk factors
for the initiation or progression of periodontal disease.
• In 1997, Kornman et al. found an association between the
polymorphism in the genes encoding for interleukin-1α and
interleukin-1β and increased severity of periodontitis.
• PST® genetic susceptibility test - the first and only genetic
test that analyzes two interleukins (IL-1α and IL-1β) genes for
variations. IL-1 genetic susceptibility may not initiate or cause
the disease but rather may lead to earlier or more severe
disease
85.
Salivary diagnostics
• OralDNA®Labs has developed a salivary test, the
MyPerioID® PST®, that identifies a patient’s genetic
susceptibility and inherent risk to periodontal disease by
evaluating their interleukin-1 (IL-1) gene cluster,
• MyPerioPath®, that identifies the type and concentration of
13 pathogenic bacteria known to cause periodontal disease.
86.
Conclusion
• In periodontology,the success of any treatment is dependent
upon the accuracy of the initial diagnosis.
• At present, the majority of chronic periodontitis cases can be
adequately managed using existing diagnostic methodology,
although it is clearly more desirable to be able to diagnose
“active disease” as it occurs, rather than months later.
• However, the clinician must ensure that the use of such tests
will benefit the patients in terms of both the value of
diagnostic data obtained and the cost in time and money.
87.
References
• Carranza’s ClinicalPeriodontology 10th and 11th edition.
• Armitage GC, Jeffcoat MK, Chadwick DE: longitudinal
evaluation of elastase as a marker for the progression of
Periodontitis, J Periodontol 1994; 65:120.
• Beck JD: Issues in assessment of diagnostic tests and risk for
Periodontal diseases, Periodontol 2000;7:100